AAVLINK breaks the cargo barrier

Puntos clave

• AAVLINK significantly improves genetic delivery outcomes compared to conventional methods, showing enhanced efficacy.
• Increased cargo capacity can lead to better clinical applications in gene therapy, potentially transforming treatment options.
• Assessment of viral vectors demonstrated AAVLINK's ability to overcome existing limitations in cargo transfer efficiency.
• This breakthrough may enable more effective gene therapy treatments in the future, expanding therapeutic possibilities.